- Home
- Publications
- Publication Search
- Publication Details
Title
Application of lipid-based nanoparticles in cancer immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-08
DOI
10.3389/fimmu.2022.967505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent advances in biomaterial-boosted adoptive cell therapy
- (2022) Yonger Xue et al. CHEMICAL SOCIETY REVIEWS
- Lipids as Regulators of Cellular Senescence
- (2022) Shruthi Hamsanathan et al. Frontiers in Physiology
- A Route to Lipid ALC‐0315: a Key Component of a COVID‐19 mRNA Vaccine
- (2022) Fariba Saadati et al. CHEMISTRY-A EUROPEAN JOURNAL
- Safe Nanoparticles: Are We There Yet?
- (2021) Wided Najahi-Missaoui et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma
- (2021) Ting Wei et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Self-assembled mRNA vaccines
- (2021) Jeonghwan Kim et al. ADVANCED DRUG DELIVERY REVIEWS
- Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing
- (2021) Shuai Liu et al. NATURE MATERIALS
- Targeting Innate Immunity in Cancer Therapy
- (2021) Srikrishnan Rameshbabu et al. Vaccines
- Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies
- (2021) Bing-Mae Chen et al. ACS Nano
- Lipid Nanoparticles—From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
- (2021) Rumiana Tenchov et al. ACS Nano
- CpG-Based Nanovaccines for Cancer Immunotherapy
- (2021) Wenqiang Chen et al. International Journal of Nanomedicine
- Nanoparticle‐Mediated STING Agonist Delivery for Enhanced Cancer Immunotherapy
- (2021) Qinghao Zhou et al. MACROMOLECULAR BIOSCIENCE
- Long Chain Fatty Acids as Modulators of Immune Cells Function: Contribution of FFA1 and FFA4 Receptors
- (2021) Maria A. Hidalgo et al. Frontiers in Physiology
- Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
- (2021) Alexander J. Stephens et al. Frontiers in Immunology
- Lipid nanoparticles for mRNA delivery
- (2021) Xucheng Hou et al. Nature Reviews Materials
- Recent advances of biomaterials in stem cell therapies
- (2021) Yonger Xue et al. NANOTECHNOLOGY
- CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
- (2021) Zhongkun Zhang et al. Pharmaceutics
- A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod
- (2021) Zhongkun Zhang et al. Pharmaceutics
- Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
- (2021) Griffin Pauli et al. Pharmaceutics
- Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
- (2020) Margaret M. Billingsley et al. NANO LETTERS
- A Synthetic Carrier of Nucleic Acids Structured as a Neutral Phospholipid Envelope Tightly Assembled on Polyplex Surface
- (2020) Yonger Xue et al. Advanced Healthcare Materials
- Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
- (2020) Itziar Gómez-Aguado et al. Nanomaterials
- Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer
- (2020) Parvin Zamani et al. EUROPEAN JOURNAL OF CANCER
- Liposomes as tunable platform to decipher the antitumor immune response triggered by TLR and NLR agonists
- (2020) Célia Jacoberger-Foissac et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A phase I study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral (iTu) injection alone and in combination with durvalumab.
- (2020) Manish R. Patel et al. JOURNAL OF CLINICAL ONCOLOGY
- Lipid nanoparticles for nucleic acid delivery: Current perspectives
- (2020) Eleni Samaridou et al. ADVANCED DRUG DELIVERY REVIEWS
- Efficient Colorectal Cancer Gene Therapy with IL-15 mRNA Nano-formulation
- (2020) Sibei Lei et al. MOLECULAR PHARMACEUTICS
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- Advances in oligonucleotide drug delivery
- (2020) Thomas C. Roberts et al. NATURE REVIEWS DRUG DISCOVERY
- Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway
- (2020) Eui Ho Kim et al. eLife
- mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
- (2020) Gal Cafri et al. JOURNAL OF CLINICAL INVESTIGATION
- Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
- (2020) Maria L. Guevara et al. Frontiers in Chemistry
- Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
- (2020) Xinfu Zhang et al. Science Advances
- Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy
- (2020) Aaron J. Wilk et al. Blood Advances
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
- (2019) Anthony Conway et al. MOLECULAR THERAPY
- miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint
- (2019) Duolu Li et al. EXPERIMENTAL CELL RESEARCH
- Tumor suppressor microRNA-204-5p regulates growth, metastasis, and immune microenvironment remodeling in breast cancer
- (2019) Bok Sil Hong et al. CANCER RESEARCH
- Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles
- (2019) Cory D. Sago et al. Cellular and Molecular Bioengineering
- A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
- (2019) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
- (2019) Kimberly J. Hassett et al. Molecular Therapy-Nucleic Acids
- Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
- (2019) Beatriz García-Pinel et al. Nanomaterials
- MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer
- (2019) Parvin Zamani et al. JOURNAL OF CONTROLLED RELEASE
- Immunomodulatory Nanosystems
- (2019) Xiangru Feng et al. Advanced Science
- Lipid-based nanoparticle formulations for small molecules and RNA drugs
- (2019) Ludger M. Ickenstein et al. Expert Opinion on Drug Delivery
- Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
- (2019) Lei Miao et al. NATURE BIOTECHNOLOGY
- Targeted Delivery of siRNA Lipoplexes to Cancer Cells Using Macrophage Transient Horizontal Gene Transfer
- (2019) Elizabeth C. Wayne et al. Advanced Science
- Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response
- (2019) Mahnaz Sahraei et al. JOURNAL OF CLINICAL INVESTIGATION
- Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice
- (2019) Lisa Munakata et al. JOURNAL OF CONTROLLED RELEASE
- Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
- (2019) F. Zhang et al. Nature Communications
- The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
- (2019) Zuzanna Urban-Wojciuk et al. Frontiers in Immunology
- Nanoparticles versus Dendritic Cells as Vehicles to Deliver mRNA Encoding Multiple Epitopes for Immunotherapy
- (2019) Rebuma Firdessa-Fite et al. Molecular Therapy-Methods & Clinical Development
- Delivery of a Modified mRNA Encoding IL-22 Binding Protein (IL-22BP) for Colon Cancer Gene Therapy
- (2018) Rui Zhang et al. Journal of Biomedical Nanotechnology
- A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates
- (2018) Staci Sabnis et al. MOLECULAR THERAPY
- Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
- (2018) David R. Wilson et al. Nanomedicine-Nanotechnology Biology and Medicine
- Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters
- (2018) Colin J. McKinlay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
- (2018) Jonathan D. Finn et al. Cell Reports
- The application of CAR-T cell therapy in hematological malignancies: Advantages and challenges
- (2018) Zijun Zhao et al. Acta Pharmaceutica Sinica B
- Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune response
- (2018) Hirotaka Imai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Therapeutically active RIG-I agonist induces immunogenic tumor cell killing in breast cancers
- (2018) David L Elion et al. CANCER RESEARCH
- An RNA toolbox for cancer immunotherapy
- (2018) Fernando Pastor et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
- (2018) Ruchi Jain et al. Nucleic Acid Therapeutics
- Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies
- (2018) Toshiki Iwai et al. Oncotarget
- The suppressive effect of co-inhibiting PD-1 and CTLA-4 expression on H22 hepatomas in mice
- (2018) Leilei Liang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer
- (2018) Manisit Das et al. MOLECULAR THERAPY
- Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
- (2018) Ian Lai et al. Journal for ImmunoTherapy of Cancer
- Effect of TLR ligands co-encapsulated with multiepitopic antigen in nanoliposomes targeted to human DCs via Fc receptor for cancer vaccines
- (2017) Felix Rueda et al. IMMUNOBIOLOGY
- Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA
- (2017) Rein Verbeke et al. JOURNAL OF CONTROLLED RELEASE
- Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers
- (2017) Elizabeth L. Siegler et al. MOLECULAR THERAPY
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
- (2017) James E. Dahlman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systemic delivery of factor IX messenger RNA for protein replacement therapy
- (2017) Suvasini Ramaswamy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo
- (2017) Xi Zhu et al. Theranostics
- Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
- (2017) Jane Cullis et al. Cancer Immunology Research
- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- Super natural killer cells that target metastases in the tumor draining lymph nodes
- (2016) Siddarth Chandrasekaran et al. BIOMATERIALS
- Toxicities of chimeric antigen receptor T cells: recognition and management
- (2016) Jennifer N. Brudno et al. BLOOD
- Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response
- (2016) Arup Garu et al. MOLECULAR THERAPY
- Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
- (2016) Matthias A. Oberli et al. NANO LETTERS
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Opposing effects of alcohol on the immune system
- (2016) Tasha Barr et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8+T cell immunity
- (2015) Y.-H. Ahn et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma
- (2015) Hidetaka Akita et al. JOURNAL OF CONTROLLED RELEASE
- An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo
- (2015) Bin Li et al. NANO LETTERS
- Immune activation by medium-chain triglyceride-containing lipid emulsions is not modulated by n-3 lipids or toll-like receptor 4
- (2015) Evelyn D. Olthof et al. TOXICOLOGY IN VITRO
- A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression
- (2015) Sisi Ma et al. Oncotarget
- Killing cancer cells using nanotechnology: novel poly(I:C) loaded liposome–silica hybrid nanoparticles
- (2015) Valentina Colapicchioni et al. Journal of Materials Chemistry B
- MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
- (2015) Paula Codo et al. Oncotarget
- Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity
- (2014) Eleni Maria Varypataki et al. AAPS Journal
- A new adjuvant delivery system ‘cyclic di-GMP/YSK05 liposome’ for cancer immunotherapy
- (2014) Hiroko Miyabe et al. JOURNAL OF CONTROLLED RELEASE
- Targeted siRNA Silencing of Indoleamine 2, 3-Dioxygenase in Antigen-presenting Cells Using Mannose-conjugated Liposomes
- (2014) Di Chen et al. JOURNAL OF IMMUNOTHERAPY
- Attenuated A20 expression of acute myeloid leukemia-derived dendritic cells increased the anti-leukemia immune response of autologous cytolytic T cells
- (2014) Xiaoying Zhang et al. LEUKEMIA RESEARCH
- Combinational Delivery of Hydrophobic and Hydrophilic Anticancer Drugs in Single Nanoemulsions To Treat MDR in Cancer
- (2014) Yan Ma et al. MOLECULAR PHARMACEUTICS
- Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
- (2014) Y. Dong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo
- (2014) Aws Alshamsan et al. Translational Oncology
- Nanoemulsion: an advanced mode of drug delivery system
- (2014) Manjit Jaiswal et al. 3 Biotech
- Lipid antigens in immunity
- (2013) C. Marie Dowds et al. BIOLOGICAL CHEMISTRY
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Innate immune pathways in afferent lymph following vaccination with poly(I:C)-containing liposomes
- (2013) Melissa L Burke et al. Innate Immunity
- Developing Lipid Nanoparticle-Based siRNA Therapeutics for Hepatocellular Carcinoma Using an Integrated Approach
- (2013) Leiming Li et al. MOLECULAR CANCER THERAPEUTICS
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
- (2013) Martin A Maier et al. MOLECULAR THERAPY
- miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis
- (2013) Yun Zhang et al. NATURE CELL BIOLOGY
- MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene
- (2013) J Yang et al. ONCOGENE
- Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation
- (2012) Willemijn Hobo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cellsin vitroin a TLR4-independent manner
- (2012) Tillmann Michels et al. Journal of Immunotoxicology
- Abstract C36: MBP-426, a novel liposome-encapsulated oxaliplatin, in combination with 5-FU/leucovorin (LV): Phase I results of a Phase I/II study in gastro-esophageal adenocarcinoma, with pharmacokinetics
- (2012) N. N. Senzer et al. MOLECULAR CANCER THERAPEUTICS
- Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma Patients
- (2012) An MT Van Nuffel et al. MOLECULAR THERAPY
- Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells
- (2012) Shan Wan et al. PLoS One
- A20 Silencing by Lipid Envelope-Type Nanoparticles Enhances the Efficiency of Lipopolysaccharide-Activated Dendritic Cells
- (2011) Shota Warashina et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome
- (2011) Kristin A. D. Sauter et al. CANCER BIOLOGY & THERAPY
- Immunological effects of Taxol and Adryamicin in breast cancer patients
- (2011) C. Panis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells
- (2011) Helen Conroy et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
- (2011) M. Hong et al. CANCER RESEARCH
- Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer
- (2011) Tzu-Ting Huang et al. CANCER SCIENCE
- Mifamurtide for the treatment of nonmetastatic osteosarcoma
- (2011) Kosei Ando et al. EXPERT OPINION ON PHARMACOTHERAPY
- siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions
- (2011) K Iwamura et al. GENE THERAPY
- Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
- (2011) Ming-Kung Yeh et al. International Journal of Nanomedicine
- Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
- (2011) Yuting Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Knockdown of HMGB1 in Tumor Cells Attenuates Their Ability To Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-Dependent Antitumor Immunity
- (2011) Z. Liu et al. JOURNAL OF IMMUNOLOGY
- The effect of neutral helper lipids on the structure of cationic lipid monolayers
- (2011) A. P. Dabkowska et al. Journal of the Royal Society Interface
- Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
- (2010) Katrin Knop et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Mitoxantrone-Mediated Apoptotic B16-F1 Cells Induce Specific Anti-tumor Immune Response
- (2010) Chunyu Cao et al. Cellular & Molecular Immunology
- Lentiviral-mediated Foxp3 RNAi suppresses tumor growth of regulatory T cell-like leukemia in a murine tumor model
- (2010) B-Y Tsai et al. GENE THERAPY
- Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation☆
- (2010) Hidetaka Akita et al. JOURNAL OF CONTROLLED RELEASE
- STAT3 Silencing in Dendritic Cells by siRNA Polyplexes Encapsulated in PLGA Nanoparticles for the Modulation of Anticancer Immune Response
- (2010) Aws Alshamsan et al. MOLECULAR PHARMACEUTICS
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- Lipid-like materials for low-dose, in vivo gene silencing
- (2010) K. T. Love et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Edible nanoemulsions: fabrication, properties, and functional performance
- (2010) David Julian McClements Soft Matter
- Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets
- (2009) Shijun Kang et al. IMMUNOBIOLOGY
- Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity
- (2009) Juan R. Cubillos-Ruiz et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy
- (2008) Lei Zhang et al. CLINICAL IMMUNOLOGY
- The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine
- (2008) Kaley D. Wilson et al. JOURNAL OF GENE MEDICINE
- Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
- (2008) Noam Stern-Ginossar et al. NATURE IMMUNOLOGY
- A20 is an antigen presentation attenuator and its inhibition overcomes regulatory T cell–mediated suppression
- (2008) Xiao-Tong Song et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started